Paul Mampilly has been the Senior Editor at Banyan Hill Publishing since 2016. Paul has found great joy in helping other people get a grasp on what it means to be successful. He learned his craft on Wall Street as a portfolio manager. Paul began his career there and soon moved forward to Deutsche Bank and ING. He played direct roles in managing multi million-dollar accounts while at the company. He was eventually recruited by Kinetics Asset Management to lead their hedge fund. The asset grew at an incredible rate. Eventually it reached 25 billion dollars under Paul’s management. Barrons recognized it as one of the world’s best hedge funds due to a 26% annual return.
Organizers of an investment competition solicited Paul for his participation. He entered the contest with an investment of $50 million dollars. Paul Mampilly was able to produce returns in one year of 88 million dollars. These achievements are significant because Paul was able to accomplish this during the 2008 and 2009 financial crisis.
Paul soon developed an urge to step away from the Wall Street scene. He began to lose taste for helping the 1% get richer than they were. Mampilly retired from his investment role in order to reconnect with his family. However, Paul is not leading a sedentary life while in retirement.
Paul Mampilly’s new passion is showing the average person the tricks of the trade that make the super rich successful. He began a newsletter call Profits Unlimited and Extreme Fortunes. The letter became very popular as a research tool.
Profits Unlimited is a provider of information that allows the common investor to get in on some sophisticated knowledge. The publication allows him to reach a demographic that was out of his grasp on Wall Street. Paul is satisfied with removing himself from Wall Street and returning to the foundation of his craft.
Mampilly is very dedicated to the information he gives out and conducts extensive research in order to recommend the right stocks for his followers. He has a skilled team that helps him make decisions on various tasks and ideas. They conduct thorough research and investigation in order to get all of the details in perfect condition. This is the reason Paul is always confident that he is putting out information that will help the average person build a successful portfolio. Paul and his team are also able to generate real life scenarios in order to present a more clear image of how certain investment circumstances could workout.
For more info: banyanhill.com/expert/paul-mampilly/
In 2010 Jason Hope, a well-known entrepreneur, futurist, philanthropist, and technologists donated $500,000 to SENs research Foundation. His donation was geared towards constructing the Cambridge SENs Laboratory as well as starting a new research program. In a statement after the contribution, Jason Hope indicated that he was privileged to have contributed towards the organization’s anti-aging research. He said that the donation would help cure degenerative diseases that make people age unnecessarily fast. He gave examples of lung diseases and Alzheimer’s disease saying that these disorders not only affect the lung and the brain respectively but also lead to premature aging.
AGE Breaker Program
With the donation, SENs foundation has developed AGE-breaker program. This marks a significant milestone as a drug has to be able to break down advanced glycation end (AGE) for it to qualify being called AGE-breaker. AGE is a metabolic waste that fastens degenerative process in the body. It is tied to age-related diseases such as osteoporosis, Parkinson’s, arthritis and Alzheimer’s. AGE leads to loss of elasticity of blood vessels and skin in aged people. These diseases are referred to as age-related as they are caused by the degenerative action of the body cells that happen at old age. Since there has been little research on these disorders, the Scottsdale, Arizona-based philanthropist felt that it is a sector worth investing.
Over the last few decades, AGE-breaking studies and treatments have failed. This failure has been attributed to the use of animals in the lab expecting the results to be replicated in human beings. Results in human have been very different to results in animals as the latter is short-lived. Additionally, animals and humans have distinct genetic makeup, and thus results cannot be easily replicated in humans.
Today, researchers have understood the difference between human and animal experiments and found glucosepane, a protein in human AGE that is thought to be a significant breakthrough. With the discovery of this protein, Jason Hope will go down in history as one of the philanthropists who donated towards this great invention. With this finding, researchers are expected to eliminate the AGEs that are present in degenerative diseases, consequently increasing the lifespan of people suffering from degenerative disorders.
About Jason Hope
Jason Hope is an investor, futurist, philanthropist and entrepreneur based in Scottsdale, Arizona. He is globally known for his passion towards charitable activities and technology. Hope holds a degree in finance from the Arizona State University. He also holds an MBA from the Arizona State University’s W.P. Carey School of Business. Hope is a great believer of the Internet of Things (IoT).
Jason Hope Info: www.facebook.com/jason.r.hope
James Dondero has enjoyed a highly successful career in the banking industry. The Co-Founder and President of Highland Capital Management has decades of experience in the credit and equity markets. Under Dondero’s leadership, the company has won numerous awards for its products and solutions for both retail and institutional investors.
In 1984, Dondero was accepted into what’s called the Morgan Guaranty program, which is where he started his career. That same year, he graduated from college. He holds certificate in chartered financial analyst and certified management accountant. Read more about James Dondero at Daily Forex Report.
In 1985, American Express hired Dondero as a corporate bond analysis. It didn’t take him long to move up the ranks, as he eventually became a portfolio manager at the company. He managed around a billion dollars in fixed income funds. He left American Express in 1989.
Prior to finding Highland, James Dondero worked at subsidiary of Protective Life. He was the Chief Investment Officer of GIV, which was founded in 1989. Under his leadership, GIV grew to over a billion dollars. Visit his website at jamesdondero.com.
Dondero sits on the board of numerous companies. CCS Medical, NexBank, Cornerstone Healthcare and NexPoint are a few of them. Not only that, but he supports various charitable activities. This includes Perot Museum of Natural Science and Snowball Express. Other charitable activities he supports includes Education is Freedom and Uplift Education.
Dondero is also active on social media, where he likes to post things related to his career. He writes for the Huffington Post from time to time, and he maintains a Facebook, Twitter, YouTube and LinkedIn account.